发布: 2019年09月05日第9卷第17期 DOI: 10.21769/BioProtoc.3348 浏览次数: 6372
评审: Alessandro DidonnaPamela MaherMarzia Di Donato
Abstract
Robust and efficient gene expression control enables the study of a gene’s function in the central nervous system. Advances in CRISPR-based technology provide new avenues not only for gene editing, but for complex transcriptional control. Here, we describe a protocol to generate high-titer lentiviruses with neuron-optimized CRISPR-activation constructs (dual lentiviruses consisting of a gene-specific single guide RNA and the CRISPR-activator) for use in primary neurons in vitro or in the adult brain in vivo. This protocol enables modular, scalable, and multiplexable gene regulation in the nervous system and does not require a transgenic model organism.
Keywords: CRISPR-Cas9 (CRISPR-Cas9)Background
The study of gene expression in the central nervous system is challenging due to difficulties in transgene delivery in post-mitotic neurons. Approaches to induce gene expression have typically relied on the use of transgenic animal models (Ericsson et al., 2013) and viral overexpression vectors (Prelich, 2012). These techniques are resource and time-consuming to make, neglect the endogenous gene locus, are limited by viral cargo capacities, and generally only target one gene at a time. CRISPR-Cas9 gene editing technology has been adapted to recruit effector proteins, such as transcriptional activators, to enable precise control over transcription (Chavez et al., 2015; Savell and Day, 2017). We recently optimized a CRISPR-activation (CRISPRa) system for robust, specific, titratable, and multiplexable gene induction in neurons both in vitro and in vivo by adapting available CRISPRa tools to be expressed with a dual lentivirus approach (Savell et al., 2019). This dual lentivirus system is composed of lentiviruses containing a gene-specific single guide RNA (sgRNA) and the dCas9-VPR (a strong transcriptional activator). Multiplexing at a single gene involves recruiting multiple dCas9-VPR effectors to a single gene’s promoter to boost transcription of that gene by pooling sgRNAs targeting the same gene. Multiplexing multiple genes is possible through combining sgRNAs targeting each of the desired genes.
This protocol is divided into subsections to outline 1) identification of sgRNA targeting sequences for CRISPRa and cloning the targeting sequence into the sgRNA scaffold, 2) maintaining and using HEK293T cells for lentivirus production, 3-4) lentivirus preparations on different scales for use in vitro and in vivo, 5) transduction guidelines for in vitro applications, 6) Transduction of adult neurons in vivo.
Part I: Identification of sgRNA targeting sequence for CRISPRa at gene promoters and cloning the target sequence into the sgRNA scaffold
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
神经科学 > 细胞机理 > 组织分离与培养
分子生物学 > DNA > 基因表达
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link